Excision BioTherapeutics Patents – Key Insights and Stats

Excision BioTherapeutics has a total of 76 patents globally, out of which 2 have been granted. Of these 76 patents, more than 19% patents are active. The United States of America is where Excision BioTherapeutics has filed the maximum number of patents, followed by Japan and Canada. Parallelly, The United States of America seems to be the main focused R&D center and also USA is the origin country of Excision BioTherapeutics.

Excision BioTherapeutics was founded in 2015. Excision The Company operates as a biotechnology company. The Company develops gene editing therapeutics and medicines for the treatment of patients with disease caused by viral infections.

Do read about some of the most popular patents of Excision BioTherapeutics which have been covered by us in this article and also you can find Excision BioTherapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Excision BioTherapeutics patent portfolio.

How many patents does the Founder and CEO of Excision BioTherapeutics have?

The Founder Rob Simmons has 15 patents and Thomas Malcolm has 21 has patents and the CEO Daniel Dombusch has 0 patent.

How many patents does Excision BioTherapeutics have?

Excision BioTherapeutics has a total of 76 patents globally. These patents belong to 16 unique patent families. Out of 76 patents, 15 patents are active.

How Many Patents did Excision BioTherapeutics File Every Year?

Excision BioTherapeutics Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantExcision BioTherapeutics Applications FiledExcision BioTherapeutics Patents Granted

How many Excision BioTherapeutics patents are Alive/Dead?

Worldwide Patents

Excision BioTherapeutics Patent Portfolio

 How Many Patents did Excision BioTherapeutics File in Different Countries?

Excision BioTherapeutics Worldwide Patent Filing

 Countries in which Excision BioTherapeutics Filed Patents

United States Of America14
Hong Kong (S.A.R.)4
New Zealand1

Where are Research Centers of Excision BioTherapeutics Patents Located?

R&D Centers of Excision BioTherapeutics

 10 Best Excision BioTherapeutics Patents

WO2017132112A1 is the most popular patent in the Excision BioTherapeutics portfolio. It has received 35 citations so far from companies like Shenzhen Sanzhi Medical Technology.

Below is the list of 10 most cited patents of Excision BioTherapeutics:

Publication NumberCitation Count

What Percentage of Excision BioTherapeutics US Patent Applications were Granted?

Excision BioTherapeutics (Excluding its subsidiaries) has filed 11 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 2 have been granted leading to a grant rate of 18.18%.

Below are the key stats of Excision BioTherapeutics patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Excision BioTherapeutics?

Law FirmTotal ApplicationsSuccess Rate
Kohn & Associates911.11%
Wilson Sonsini Goodrich & Rosati250.00%

What are Excision BioTherapeutics key innovation segments?

What Technologies are Covered by Excision BioTherapeutics?

The chart below distributes patents filed by Excision BioTherapeutics in different countries on the basis of the technology protected in patents. It also represents the markets where Excision BioTherapeutics thinks it’s important to protect particular technology inventions.

R&D Focus: How has Excision BioTherapeutics search focus changed over the years?


Interested in knowing about the areas of innovation that are being protected by Excision BioTherapeutics?

Leave a Comment

Table of Content

Popular Topics

Insights you may find interesting